McDermott Will & Emery has advised eureKARE on the deal. eureKARE, investment company focused on financing and developing synthetic biology innovation across Europe, announced the creation...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here